Citation Impact
Citing Papers
Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study
2008 Standout
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
2011 Standout
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
2011 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF
2005
Gastric cancer
2016 Standout
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
Platinum-based chemotherapy in metastatic breast cancer: current status
2003
Synergistic cytotoxicity of the ribonucleotide reductase inhibitor didox (3,4-dihydroxy-benzohydroxamic acid) and the alkylating agent carmustine (BCNU) in 9L rat gliosarcoma cells and DAOY human medulloblastoma cells
2004
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
2006 Standout
Body Fatness and Cancer — Viewpoint of the IARC Working Group
2016 Standout
Photodynamic Therapy
1998 Standout
A multicentre, double-blind study comparing placebo, ondansetron and ondansetron plus dexamethasone for the control of cisplatin-induced delayed emesis
1996
Cancer to bone: a fatal attraction
2011 Standout
Nausea and Vomiting Remain a Significant Clinical Problem
2000
Role of maintenance oral dexamethasone in prophylaxis of delayed emesis caused by moderately emetogenic chemotherapy
1996
Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics
1991
5-HT3 Receptor Antagonists for the Prevention of Chemotherapy-Induced Nausea and Vomiting
1998
Comparison of single-dose oral granisetron versus intravenous ondansetron in the prevention of nausea and vomiting induced by moderately emetogenic chemotherapy: a multicenter, double-blind, randomized parallel study.
1998
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Indolent CD8-positive Lymphoid Proliferation of the Ear
2007
High-dose methotrexate: a critical reappraisal.
1987
Double-blind randomised trial of the antiemetic efficacy and safety of ondansetron and metoclopramide in advanced breast cancer patients treated with epirubicin and cyclophosphamide
1991
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
Delayed emesis: incidence, pattern, prognostic factors and optimal treatment
2002
Efficacy and tolerability of aprepitant for the prevention of chemotherapy‐induced nausea and emesis over multiple cycles of moderately emetogenic chemotherapy
2005
Effect of schedule and maintenance on the antiemetic efficacy of ondansetron combined with dexamethasone in acute and delayed nausea and emesis in patients receiving moderately emetogenic chemotherapy: a phase III trial by the National Cancer Institute of Canada Clinical Trials Group.
1994
State of the art in the delivery of photosensitizers for photodynamic therapy
2002
Guillain–Barré Syndrome
2012 Standout
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review
2001
Parathyroid hormone related protein and skeletal morbidity in breast cancer
1992
Photodynamic therapy for cancer
2003 Standout
A new wave of serotonin receptors
1993 StandoutNobel
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Single-dose oral granisetron has equivalent antiemetic efficacy to intravenous ondansetron for highly emetogenic cisplatin-based chemotherapy.
1998
Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function
1995
Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
2009
Analysis of cumulative probabilities shows that the efficacy of 5HT3 antagonist prophylaxis is not maintained.
1996
Cellular processing of platinum anticancer drugs
2005 Standout
Drug Treatment of Chemotherapy-Induced Delayed Emesis
1996
Oesophageal carcinoma
2013 Standout
Simple nontoxic treatment of advanced metastatic seminoma with carboplatin.
1989
A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer
2005
Chemotherapy-Induced Nausea and Vomiting
2008 Standout
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer
1991 Standout
Capecitabine: A review
2005
A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
2004
THE EFFECTS OF PLASMA LIPOPROTEINS ON in vitro TUMOR CELL KILLING and in vivo TUMOR PHOTOSENSITIZATION WITH BENZOPORPHYRIN DERIVATIVE
1991
Evaluation of the prognostic value of systemic inflammation and socioeconomic deprivation in patients with resectable colorectal liver metastases
2008
Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer.
1992 Standout
Gastric cancer
2020 Standout
Cannabinoids in medicine: A review of their therapeutic potential
2006
Primary brain tumours in adults
2012 Standout
Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists
1994
Role of Formulation Vehicles in Taxane Pharmacology
2001
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Control of Chemotherapy-Induced Emesis
1993
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy
1991
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
2007
Mechanisms of Bone Metastasis
2004 Standout
Therapeutic use ofCannabis sativaon chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis
2008
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Parathyroid Hormone-Related Protein: Elevated Levels in both Humoral Hypercalcemia of Malignancy and Hypercalcemia Complicating Metastatic Breast Cancer*
1991
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
2008 Standout
Further Regional Variants of Acute Immune Polyneuropathy
1994
Cancer control in women. Update 2003
2003
New drugs in the treatment of colorectal carcinoma
1998
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
HEPATOSPLENIC CANDIDIASIS
2000
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy
1984
Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer.
1985
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
Primary Structure And Functional Expression of the 5HT 3 Receptor, A Serotonin-gated Ion Channel
1991 StandoutScienceNobel
Phase III Trial of Nanoparticle Albumin-Bound Paclitaxel Compared With Polyethylated Castor Oil–Based Paclitaxel in Women With Breast Cancer
2005 Standout
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium
2012
Nanoparticles in Photodynamic Therapy
2015 Standout
Mechanisms of bone metastasis
1997
Delayed Nausea and Vomiting Continue to Reduce Patients' Quality of Life After Highly and Moderately Emetogenic Chemotherapy Despite Antiemetic Treatment
2006
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
1999
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
Pharmacological Effects of Formulation Vehicles
2003
Proposal for classifying the acute emetogenicity of cancer chemotherapy.
1997 Standout
Clinical Features of Metastatic Bone Disease and Risk of Skeletal Morbidity
2006 Standout
Contribution of Dexamethasone to Control of Chemotherapy-Induced Nausea and Vomiting: A Meta-Analysis of Randomized Evidence
2000
High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma
1985
Cannabinoids for Medical Use
2015 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy
1986
Trends in the Aggressiveness of Cancer Care Near the End of Life
2004 Standout
Phase II Multicenter Study of Brief Single-Agent Methotrexate Followed by Irradiation in Primary CNS Lymphoma
2000
The Oral Neurokinin-1 Antagonist Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients Receiving High-Dose Cisplatin—The Aprepitant Protocol 052 Study Group
2003 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Works of M. Soukop being referenced
Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
1985
Randomised trial of intravenous high dose metoclopramide and intramuscular chlorpromazine in controlling nausea and vomiting induced by cytotoxic drugs.
1985
A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma
2002
A dose-finding study of granisetron, a novel antiemetic, in patients receiving high-dose cisplatin
1994
Improving prognosis of Hodgkin's disease in Scotland
1988
Tropisetron alone or in combination with dexamethasone for the prevention and treatment of emesis induced by non-cisplatin chemotherapy
1995
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues
1988
A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT) in patients with advanced oesophageal and gastric adenocarcinoma
2001
Ondansetron Compared with Metoclopramide in the Control of Emesis and Quality of Life during Repeated Chemotherapy for Breast Cancer
1992
Management of Cyclophosphamide-lnduced Emesis over Repeat Courses
1996
A pilot study of combination therapy with interferon-α-2a and 5-fluorouracil in metastatic carcinoid and malignant endocrine pancreatic tumours
1996
Improved Control of Emesis and Quality of Life with Ondansetron in Breast Cancer
1993
Pharmacokinetics and anti-emetic efficacy of BRL43694, a new selective 5HT-3 antagonist
1988
Phase II trial of didox in advanced breast cancer
1991
Breast Cancer-Associated Hypercalcaemia: A Reassessment of Renal Calcium and Phosphate Handling
1990
The pharmacokinetics of high dose cyclophosphamide and high dose etoposide
1988
Hypothesis: symmetrical cutaneous lymphoma
1990
Etoposide: A pharmacokinetic profile including an assessment of bioavailability
1986
Low-density lipoprotein metabolism in mice with soft tissue tumours
1984
Functional and structural changes of the human proximal small intestine after cytotoxic therapy.
1985
Influence of polysorbate 80 (Tween 80) and etoposide (VP-16-213) on the pharmacokinetics and urinary excretion of adriamycin and its metabolites in cancer patients
1986
Comparison of serum and cerebrospinal fluid levels of methotrexate in man during high-dose chemotherapy for aggressive non-Hodgkin's lymphoma
1985
The systemic inflammatory response predicts overall and cancer specific survival in patients with malignant lymphoma.
2005
Treatment of small cell carcinoma of lung with late dosage intensification programmes containing cyclophosphamide and mesna
1983
Hypersplenism due to fungal infection of spleen in a successfully treated patient with Hodgkin’s disease
1989
A randomised multicentre single blind comparison of a cannabinoid anti-emetic (Levonantradol) with chlorpromazine in patients receiving their first cytotoxic chemotherapy
1983